Merrimack Pharmaceuticals Inc (MACK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 15,735 | 18,025 | 16,580 | 20,858 | 37,501 |
| Marketable Securities | N/A | N/A | N/A | N/A | 2,987 |
| TOTAL | $19,366 | $19,972 | $18,692 | $22,398 | $42,557 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 315 | 1,369 | 1,390 | 2,443 | 2,483 |
| TOTAL | $315 | $1,369 | $1,390 | $2,443 | $2,483 |
| Total Assets | $19,681 | $21,341 | $20,082 | $24,841 | $45,040 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,279 | 3,240 | 2,714 | 4,683 | 4,940 |
| Other current liabilities | 56 | 56 | 56 | 56 | 0 |
| TOTAL | $2,335 | $3,296 | $2,770 | $4,739 | $4,940 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 56 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $56 |
| Total Liabilities | $2,335 | $3,296 | $2,770 | $4,739 | $4,996 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 13,380 | 13,380 | 13,380 | 13,363 | 13,350 |
| Common Shares | 1,334 | 1,334 | 1,334 | 1,334 | 1,334 |
| Retained earnings | -541,523 | -540,360 | -540,609 | -543,870 | -543,165 |
| TOTAL | $17,346 | $18,045 | $17,312 | $20,102 | $40,044 |
| Total Liabilities And Equity | $19,681 | $21,341 | $20,082 | $24,841 | $45,040 |